AE Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Sell |
1,601
-410
| -20% | -$51.9K | ﹤0.01% | 1306 |
|
|
2025
Q1 | $257K | Sell |
2,011
-137
| -6% | -$17.5K | ﹤0.01% | 1158 |
|
|
2024
Q4 | $284K | Sell |
2,148
-98
| -4% | -$13K | ﹤0.01% | 1125 |
|
|
2024
Q3 | $327K | Buy |
2,246
+212
| +10% | +$30.9K | ﹤0.01% | 997 |
|
|
2024
Q2 | $279K | Buy |
2,034
+196
| +11% | +$26.9K | ﹤0.01% | 1052 |
|
|
2024
Q1 | $252K | Sell |
1,838
-23,270
| -93% | -$3.19M | ﹤0.01% | 1018 |
|
|
2023
Q4 | $3.4M | Buy |
25,108
+2,215
| +10% | +$300K | 0.02% | 720 |
|
|
2023
Q3 | $2.8M | Buy |
22,893
+3,467
| +18% | +$424K | 0.02% | 729 |
|
|
2023
Q2 | $2.47M | Sell |
19,426
-1,486
| -7% | -$189K | 0.01% | 775 |
|
|
2023
Q1 | $2.7M | Sell |
20,912
-3,610
| -15% | -$466K | 0.02% | 690 |
|
|
2022
Q4 | $3.22M | Sell |
24,522
-3,078
| -11% | -$404K | 0.02% | 596 |
|
|
2022
Q3 | $3.23M | Buy |
27,600
+5,698
| +26% | +$666K | 0.03% | 544 |
|
|
2022
Q2 | $2.58M | Buy |
21,902
+1,507
| +7% | +$177K | 0.02% | 583 |
|
|
2022
Q1 | $2.66M | Buy |
20,395
+1,463
| +8% | +$191K | 0.02% | 628 |
|
|
2021
Q4 | $2.89M | Buy |
18,932
+9,099
| +93% | +$1.39M | 0.02% | 581 |
|
|
2021
Q3 | $1.59M | Sell |
9,833
-754
| -7% | -$122K | 0.01% | 719 |
|
|
2021
Q2 | $1.73M | Buy |
10,587
+38
| +0.4% | +$6.22K | 0.02% | 678 |
|
|
2021
Q1 | $1.59M | Buy |
10,549
+1
| +0% | +$151 | 0.02% | 632 |
|
|
2020
Q4 | $1.6M | Sell |
10,548
-30
| -0.3% | -$4.55K | 0.02% | 562 |
|
|
2020
Q3 | $1.43M | Sell |
10,578
-9,537
| -47% | -$1.29M | 0.02% | 520 |
|
|
2020
Q2 | $2.75M | Sell |
20,115
-38,492
| -66% | -$5.26M | 0.04% | 326 |
|
|
2020
Q1 | $6.31M | Buy |
58,607
+45,780
| +357% | +$4.93M | 0.15% | 139 |
|
|
2019
Q4 | $1.55M | Buy |
12,827
+539
| +4% | +$65K | 0.03% | 420 |
|
|
2019
Q3 | $1.22M | Sell |
12,288
-1,466
| -11% | -$146K | 0.04% | 401 |
|
|
2019
Q2 | $1.5M | Buy |
13,754
+8,155
| +146% | +$890K | 0.05% | 298 |
|
|
2019
Q1 | $626K | Sell |
5,599
-3,274
| -37% | -$366K | 0.04% | 300 |
|
|
2018
Q4 | $856K | Sell |
8,873
-3,092
| -26% | -$298K | 0.15% | 168 |
|
|
2018
Q3 | $1.46M | Buy |
11,965
+6,460
| +117% | +$788K | 0.08% | 170 |
|
|
2018
Q2 | $605K | Buy |
5,505
+186
| +3% | +$20.4K | 0.04% | 236 |
|
|
2018
Q1 | $568K | Buy |
5,319
+3,346
| +170% | +$357K | 0.04% | 238 |
|
|
2017
Q4 | $211K | Sell |
1,973
-1,657
| -46% | -$177K | 0.02% | 389 |
|
|
2017
Q3 | $404K | Buy |
3,630
+948
| +35% | +$106K | 0.04% | 261 |
|
|
2017
Q2 | $277K | Buy |
+2,682
| New | +$277K | 0.03% | 308 |
|